DGX
48
11
EXC
54
3
WBA
43
-4
SHW
62
-6
YUM
43
-6
INTU
58
-3
EFX
30
-8
LRCX
37
-9
AIV
64
4
BA
47
2
DLTR
38
-4
AMGN
42
-4
AN
50
-5
GE
61
-3
NVDA
52
-5
KR
36
-6
MCHP
34
-2
XEL
67
2
GRMN
67
-4
HIG
66
2
DGX
48
11
EXC
54
3
WBA
43
-4
SHW
62
-6
YUM
43
-6
INTU
58
-3
EFX
30
-8
LRCX
37
-9
AIV
64
4
BA
47
2
DLTR
38
-4
AMGN
42
-4
AN
50
-5
GE
61
-3
NVDA
52
-5
KR
36
-6
MCHP
34
-2
XEL
67
2
GRMN
67
-4
HIG
66
2
Financhill
Back

Clearfield Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
25

CLFD
Clearfield

Last Price:
28.31
Seasonality Move:
22.72%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
25
Clearfield (CLFD) is a Sell

Is Clearfield a Buy, Sell or Hold?

  • The current Clearfield [CLFD] share price is $28.26. The Score for CLFD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CLFD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLFD Stock Price Chart

What is Clearfield's stock price today?

  • The Clearfield share price today is $28.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLFD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CLFD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 22.53 Sell
Chaikin Money Flow: -94936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.01 - 38.09) Sell
Bollinger Bands (100): (35.49 - 40.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CLFD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.95 Sell
20-day SMA: 35.25 Sell
50-day SMA: 36.89 Sell
200-day SMA: 35.24 Sell
8-day EMA: 32.03 Sell
20-day EMA: 34.32 Sell
50-day EMA: 36.11 Sell
200-day EMA: 36.49 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Clearfield Earnings Growth & CLFD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.18 per share, and an increase next year of $0.55 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Clearfield Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):